Form 4 for SXTP 60 DEGREES PHARMACEUTICALS, INC.
Accepted 2025-06-09 00:00:00 ET · period of report 2025-06-09 · accession 0001213900-25-052709 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-09 | 2025-06-09 | SXTP | DOW GEOFFREY S | Pres, CEO, Dir | A - Grant | $2.99 | +4,376 | 26.2K | +20% | +$13.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-09 | A | A | 4,376 | $2.99 | 26,171 | D | — | — | (F2) Reflects a 1-for-5 reverse stock split effective February 24, 2025. As a result, the reporting person's direct beneficial ownership was adjusted from 108,974 shares to 21,795 shares, and indirect beneficial ownership was adjusted from 55,596 shares to 11,119 shares. Fractional shares resulting from the split were rounded up to the nearest whole share. |